ATE371458T1 - Behandlung von hyperproliferativen zuständen von körperoberflächen - Google Patents

Behandlung von hyperproliferativen zuständen von körperoberflächen

Info

Publication number: ATE371458T1
Authority: AT; Austria
Prior art keywords: treatment; body surfaces; hyperproliferative conditions; psoriasis; relates
Prior art date: 2001-08-14

Application number

AT02754556T

Other languages

English (en)

Inventor

Thomas Christensen

Bjarne Bymose

Original Assignee

Valderm Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-14

Filing date

2002-08-12

Publication date

2007-09-15

2002-08-12 Application filed by Valderm Aps filed Critical Valderm Aps

2007-09-15 Application granted granted Critical

2007-09-15 Publication of ATE371458T1 publication Critical patent/ATE371458T1/de

Links

230000003463 hyperproliferative effect Effects 0.000 title 1
201000004681 Psoriasis Diseases 0.000 abstract 2
230000002159 abnormal effect Effects 0.000 abstract 1
229940045799 anthracyclines and related substance Drugs 0.000 abstract 1
230000024245 cell differentiation Effects 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
230000008506 pathogenesis Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229960000653 valrubicin Drugs 0.000 abstract 1
ZOCKGBMQLCSHFP-KQRAQHLDSA-N valrubicin Chemical compound O([C@H]1C[C@](CC2=C(O)C=3C(=O)C4=CC=CC(OC)=C4C(=O)C=3C(O)=C21)(O)C(=O)COC(=O)CCCC)[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1 ZOCKGBMQLCSHFP-KQRAQHLDSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Gynecology & Obstetrics (AREA)
Otolaryngology (AREA)
Toxicology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)
Farming Of Fish And Shellfish (AREA)
Treatments Of Macromolecular Shaped Articles (AREA)

AT02754556T 2001-08-14 2002-08-12 Behandlung von hyperproliferativen zuständen von körperoberflächen ATE371458T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200101218		2001-08-14

Publications (1)

Publication Number	Publication Date
ATE371458T1 true ATE371458T1 (de)	2007-09-15

Family

ID=8160668

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02754556T ATE371458T1 (de)	2001-08-14	2002-08-12	Behandlung von hyperproliferativen zuständen von körperoberflächen

Country Status (13)

Country	Link
US (2)	US7345023B2 (de)
EP (1)	EP1423126B1 (de)
JP (1)	JP4361789B2 (de)
AT (1)	ATE371458T1 (de)
AU (1)	AU2002320964B2 (de)
CY (1)	CY1107814T1 (de)
DE (1)	DE60222144T2 (de)
DK (1)	DK1423126T3 (de)
ES (1)	ES2292789T3 (de)
NZ (1)	NZ531408A (de)
PT (1)	PT1423126E (de)
SI (1)	SI1423126T1 (de)
WO (1)	WO2003015759A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2456423A2 (de)	2009-07-17	2012-05-30	Valderm APS	Behandlung von hyperproliferativen erkrankungen
WO2013026454A1 (en)	2011-08-22	2013-02-28	Valderm Aps	Treatment of clinical conditions with anthracyclines
WO2017008831A1 (en)	2015-07-10	2017-01-19	Infectopharm Arzneimittel Und Consilium Gmbh	Use of potassium hydroxide in the treatment of actinic keratosis
CN108098458B (zh) *	2017-08-09	2019-12-24	徐先顺	一种用于抗hpv6/11的凝胶剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5149710A (en) *	1985-04-01	1992-09-22	National Research Development Corporation	Pharmaceutical compositions for treating psoriasis
US4739046A (en) *	1985-08-19	1988-04-19	Luzio Nicholas R Di	Soluble phosphorylated glucan
US4946683A (en) *	1987-11-18	1990-08-07	Vestar, Inc.	Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
WO1989010122A1 (en) *	1988-04-27	1989-11-02	Yale University	Compositions and methods for treating cutaneous hyperproliferative disorders
US6231855B1 (en) *	1991-03-12	2001-05-15	Istituto Nazionale Per Lo Studio E La Cura Dei Tumori	Monoclonal antibodies as antidotes for anthracycline antibiotics
JP3251735B2 (ja) *	1992-09-25	2002-01-28	株式会社東芝	半導体集積回路装置
US5396195A (en) *	1993-12-13	1995-03-07	At&T Corp.	Low-power-dissipation CMOS oscillator circuits
US6190691B1 (en) *	1994-04-12	2001-02-20	Adolor Corporation	Methods for treating inflammatory conditions
US5900763A (en) *	1994-10-11	1999-05-04	Motorola, Inc.	Circuit and method of reducing cross-talk in an integrated circuit substrate
PT751144E (pt) *	1995-06-27	2004-12-31	Pharmachemie Bv	Novos pro-farmacos antraciclinicos, metodo para preparacao e tambem a sua utilizacao em quimioterapia selectiva
DE19720312A1 (de) *	1997-05-15	1998-11-19	Hoechst Ag	Zubereitung mit erhöhter in vivo Verträglichkeit
US5776915A (en) *	1997-08-12	1998-07-07	Clarion Pharmaceuticals Inc.	Phosphocholines of retinoids
WO1999055743A1 (en)	1998-04-28	1999-11-04	Inex Pharmaceuticals Corporation	Polyanionic polymers which enhance fusogenicity
AU3980499A (en)	1998-05-11	1999-11-29	Endowment for Research in Human Biology, Inc., The	Use of neomycin for treating angiogenesis-related diseases
ATE546457T1 (de) *	1999-03-19	2012-03-15	Waldemar Priebe	Verfahren und zusammensetzungen zur herstellung von c-3' und c-4' -anthracyclin antibiotika
JP2001345428A (ja) *	2000-03-27	2001-12-14	Toshiba Corp	半導体装置とその製造方法
US6555095B1 (en) *	2001-12-14	2003-04-29	Avon Products, Inc.	Topical compositions and methods of application

2002
- 2002-08-12 JP JP2003520718A patent/JP4361789B2/ja not_active Expired - Fee Related
- 2002-08-12 AU AU2002320964A patent/AU2002320964B2/en not_active Ceased
- 2002-08-12 DE DE60222144T patent/DE60222144T2/de not_active Expired - Lifetime
- 2002-08-12 ES ES02754556T patent/ES2292789T3/es not_active Expired - Lifetime
- 2002-08-12 US US10/486,648 patent/US7345023B2/en not_active Expired - Fee Related
- 2002-08-12 SI SI200230607T patent/SI1423126T1/sl unknown
- 2002-08-12 WO PCT/DK2002/000530 patent/WO2003015759A2/en not_active Ceased
- 2002-08-12 PT PT02754556T patent/PT1423126E/pt unknown
- 2002-08-12 EP EP02754556A patent/EP1423126B1/de not_active Expired - Lifetime
- 2002-08-12 NZ NZ531408A patent/NZ531408A/en not_active IP Right Cessation
- 2002-08-12 DK DK02754556T patent/DK1423126T3/da active
- 2002-08-12 AT AT02754556T patent/ATE371458T1/de active
2007
- 2007-11-28 CY CY20071101523T patent/CY1107814T1/el unknown
2008
- 2008-01-28 US US12/020,852 patent/US8263567B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PT1423126E (pt)	2007-12-07
WO2003015759A3 (en)	2004-03-04
NZ531408A (en)	2005-07-29
EP1423126B1 (de)	2007-08-29
US20080119546A1 (en)	2008-05-22
US8263567B2 (en)	2012-09-11
WO2003015759A2 (en)	2003-02-27
DE60222144D1 (de)	2007-10-11
ES2292789T3 (es)	2008-03-16
SI1423126T1 (sl)	2008-02-29
DK1423126T3 (da)	2008-02-04
US20040242507A1 (en)	2004-12-02
AU2002320964B2 (en)	2008-03-13
JP4361789B2 (ja)	2009-11-11
US7345023B2 (en)	2008-03-18
JP2005504765A (ja)	2005-02-17
CY1107814T1 (el)	2013-06-19
DE60222144T2 (de)	2008-05-15
EP1423126A2 (de)	2004-06-02

Legal Events

Date

Code

Title

Description

2008-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1423126

Country of ref document: EP

Publication	Publication Date	Title
CY1106628T1 (el)	2012-01-25	Τοπικες φαρμακευτικες συνθεσεις περιλαμβανουσες προανθοκυανιδινες, γλυκυρροχητινικο οξυ και τελμεστεϊνη για τη θεραπεια των δερματιτιδων
BG66080B1 (bg)	2011-03-31	Заместени тиоацетамиди
NO20024005D0 (no)	2002-08-22	Pteridinforbindelser for behandling av psoriasis
EA200100524A1 (ru)	2002-02-28	Амиды антраниловой кислоты и их применение в качестве лекарственных средств
ATE290401T1 (de)	2005-03-15	Topisch anwendbare mittel gegen nagelpilzerkrankungen
WO2003018619A3 (en)	2003-10-30	Antimicrobial and anti-inflammatory peptides
DE60228761D1 (de)	2008-10-16	Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
SE0001899D0 (sv)	2000-05-22	New compounds
ATE339187T1 (de)	2006-10-15	Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
NO20053855D0 (no)	2005-08-18	1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
ATE414526T1 (de)	2008-12-15	Zubereitungen zur behandlung von arthritischen erscheinungen
ATE256392T1 (de)	2004-01-15	Verwendung von polyaminosäurederivate als konservierungsmittel
DE69501105D1 (de)	1998-01-08	L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
BR0209541A (pt)	2004-04-20	Uso das imidazotriazinonas 2-fenil-substituìdas
BR9712141A (pt)	1999-08-31	Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BRPI0211635B8 (pt)	2021-05-25	composto ciclo-hexil-sulfona, uso do mesmo, e, composição farmacêutica
CY1107814T1 (el)	2013-06-19	Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος
BRPI0416674A (pt)	2007-02-13	tiazolidinona amidas, amidas de ácido tiazolidino carboxìlico, processos de fabricação, e uso das mesmas
MX9403032A (es)	1995-01-31	Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
DE50113974D1 (de)	2008-06-26	Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
UY26930A1 (es)	2002-04-26	Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso
TR200003451T2 (tr)	2001-04-20	Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
UY27372A1 (es)	2003-01-31	Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados
DOP2002000472A (es)	2004-05-26	Amidas de acido piperazinciclohexanocarboxilico sustituidas y su utilizacion.
DE60003074D1 (de)	2003-07-03	Fusidinsäure-derivate